Warfarin Drug Interactions
Warfarin potency is altered by numerous medications, supplements, and foods. Certain agents increase bleeding risk by enhancing anticoagulation, while others decrease efficacy and raise thrombotic risk. Regular INR monitoring and dose adjustment are required when any interacting agent is started, stopped, or dose‑changed.
High‑Risk Medications That Potentiate Warfarin
- Broad‑spectrum antibiotics (e.g., macrolides, fluoroquinolones) increase INR and may require a 25–50 % dose reduction over 6–8 weeks with close INR checks every 1–2 weeks【S2】.
- Nonsteroidal anti‑inflammatory drugs (NSAIDs) heighten bleeding risk by additive antiplatelet effects【S5】.
- Antifungal agents (e.g., fluconazole, itraconazole) inhibit CYP2C9 and raise warfarin levels【S5】.
- Vitamin K antagonists other than warfarin (e.g., acenocoumarol) can cause unpredictable INR fluctuations when co‑administered【S5】.
Medications That Reduce Warfarin Effect
- Inducers of hepatic enzymes (e.g., rifampin, carbamazepine, St. John’s wort) accelerate warfarin metabolism, lowering INR and increasing thrombotic risk【S1】【S5】.
- Certain antiepileptics (e.g., phenytoin, phenobarbital) also induce CYP2C9 and may necessitate dose escalation【S5】.
Herbal and Dietary Supplements
- Dong quai, garlic, ginkgo biloba, ginseng, green tea, and vitamin E can potentiate warfarin’s anticoagulant effect【S1】.
- St. John’s wort induces CYP enzymes and reduces warfarin efficacy【S1】.
Food‑Related Interactions
- Vitamin K‑rich foods (e.g., leafy greens) diminish warfarin effect; consistent intake is essential to maintain stable INR【S6】.
- Sudden changes in consumption of vitamin K–containing foods can cause INR variability and should be avoided【S6】.
Monitoring and Dose‑Adjustment Strategies
- Expect a 25–50 % reduction in warfarin dose when potent inhibitors are introduced; re‑check INR every 1–2 weeks until stable【S2】.
- For enzyme inducers, increase warfarin dose by 10–20 % and monitor INR closely for loss of therapeutic range【S5】.
- Counsel patients to avoid initiating or discontinuing herbal supplements without provider guidance【S1】.
- Maintain a consistent dietary pattern with regard to vitamin K intake and document any changes【S6】.
Summary of Common Interacting Agents
| Interaction Type | Examples | Clinical Impact |
|---|---|---|
| Potentiators | Macrolide antibiotics, fluoroquinolones, NSAIDs, antifungals, garlic, ginkgo biloba, vitamin E | ↑ INR → ↑ bleeding risk |
| Reductors | Rifampin, carbamazepine, phenytoin, St. John’s wort | ↓ INR → ↑ thrombotic risk |
| Food/Vitamin K | Spinach, kale, broccoli, Brussels sprouts | ↓ INR if intake increases |
| Herbal supplements | Dong quai, ginseng, green tea | Variable potentiation of anticoagulation |
Prompt identification of interacting agents and proactive INR surveillance are essential to maintain therapeutic anticoagulation and minimize adverse events.